Email
Print
Alpha-Fetoprotein Testing Market- By Cancer Type, By End Use, By Geography - Global Opportunity Analysis & Industry Forecast, 2024 - 2030
Alpha-Fetoprotein Testing Market Overview
Alpha-Fetoprotein Testing Market Size is forecast to reach $ 1,007.81 Million by 2030, at a CAGR of 6.30% during forecast period 2024-2030.Alpha-fetoprotein (AFP) is a protein generated by the liver and yolk sac of a foetus. AFP has no typical function in mature grown-ups. The alpha-fetoprotein test (AFP) is a blood test carried out to assess, diagnose, or supervise foetal distress or foetal abnormalities. It can also discover certain liver ailments and certain cancers in mature grown-ups. Neural tube defects (NTDs) are severe congenital deformities. There have been investigations on complement factors and alpha-fetoprotein as biomarkers for noninvasive prenatal diagnosis of neural tube defects recommending that an ailment prediction model based on integrated complement factor and AFP data could act as a more precise technique of noninvasive prenatal NTD diagnosis. The alpha-fetoprotein (AFP) or foetal alpha globulin is thought to operate in the foetus in an identical role to that of serum albumin postnatally. AFP is combined in both the foetal liver and the yolk sac. The AFP test is a test that is carried out at the time of pregnancy of maternal blood or foetal amniotic fluid at 16-19 weeks of gestation. Alpha-fetoprotein (AFP) is a plasma protein generated by the embryonic yolk sac and the foetal liver. AFP levels in serum, amniotic fluid, and urine operate as a screening test for congenital disabilities, chromosomal abnormalities, and certain additional mature grown-up happening tumors and pathologies.
The surging application of AFP tests for testing different cancer-associated tests and chromosomal abnormalities is set to drive the Alpha-Fetoprotein Testing Market. The accelerated development of R&D Activities is set to propel the growth of the Alpha-Fetoprotein Testing Market during the forecast period 2024-2030. This represents the Alpha-fetoprotein (AFP) Testing Industry Outlook.
Report Coverage
The report: “Alpha-Fetoprotein Testing Market Forecast (2024-2030)”, by Industry ARC, covers an in-depth analysis of the following segments of the Alpha-Fetoprotein Testing Market.
By Cancer Type: Liver Cancer, Testes Cancer, Biliary-Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others.
By End Use: Hospitals, Clinics, Others.
By Geography: North America (the U.S, Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).
Key Takeaways
- Geographically, North America Alpha-Fetoprotein Testing Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2024-2030 owing to the increasing predominance of incessant ailments and surging financing in cancer research which may involve chromosomal abnormalities in the North American region.
- Alpha-Fetoprotein Testing Market growth is being driven by the surging count of cancer cases which may involve chromosomal abnormalities and proliferating technological progress. However, the dearth of skilled specialists and dearth of awareness of diagnosis are some of the major factors hampering the growth of the Alpha-Fetoprotein Testing Market.
- Alpha-Fetoprotein Testing Market Detailed Analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Alpha-Fetoprotein Testing Market report.
Alpha-Fetoprotein Testing Market Share, By Cancer Type, 2021(%)
For more details on this report - Request for Sample
Alpha-Fetoprotein Testing Market Segment Analysis – By Cancer Type:
The Alpha-Fetoprotein Testing Market based on cancer type can be further segmented into Liver Cancer, Testes Cancer, Biliary-Tract Cancer, Stomach Cancer, Pancreatic Cancer and Others. The Liver Cancer Segment held the largest market share in 2021. This growth is owing to the surging application of Alpha-fetoprotein (AFP) Testing as a screening test for liver cancer. Alpha-fetoprotein (AFP) is a plasma protein generated by the embryonic yolk sac and the foetal liver. AFP has a sensitivity of around 70% for liver cancer. The fact that two-thirds of liver cancers generate AFP is further propelling the growth of the Liver Cancer segment.
Furthermore, the Testes Cancer segment is estimated to grow with the fastest CAGR of 5.7% during the forecast period 2022-2027 owing to the increased application of AFP Test to assist in confirming or ruling out the outcomes of other tests where Alpha-fetoprotein (AFP) is a plasma protein generated by the embryonic yolk sac and the foetal liver.
Alpha-Fetoprotein Testing Market Segment Analysis – By End Use:
The Alpha-Fetoprotein Testing Market based on end-use can be further segmented into Hospitals, Clinics, and Others. The Hospitals segment held the largest market share in 2021. This growth is owing to the progressive technologies accessible for treatment in conjunction with suitable care by specialists. Alpha-fetoprotein (AFP) Testing can be performed to detect neural tube defects and chromosomal abnormalities in the foetus. The supportive reimbursement policies and surging government initiatives for hospital treatments are further propelling the growth of this segment.
Furthermore, the Clinics segment is estimated to grow with the fastest CAGR of 5.9% during the forecast period 2024-2030, owing to the surging application of Alpha-fetoprotein screening in clinics to inspect the level of alpha-fetoprotein in the blood of the mothers at the time of pregnancy which could result in detection of neural tube defects and chromosomal abnormalities in the foetus.
Alpha-Fetoprotein Testing Market Segment Analysis – By Geography:
The Alpha-Fetoprotein Testing Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Alpha-Fetoprotein Testing Market) held the largest share with 38% of the overall market in 2021. The growth of this region is owing to the increasing predominance of autoimmune ailments and cancer in the region. Alpha-fetoprotein (AFP) Testing is performed to detect neural tube defects and chromosomal abnormalities in the foetus. The upsurge in R&D activities to develop novel treatments for numerous ailments is further propelling the growth of the Alpha-Fetoprotein Testing Market in the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2024-2030. This growth is owing to factors like the rising pervasiveness of incessant ailments like cancer in the Asia-Pacific region. Alpha-fetoprotein (AFP) is a plasma protein generated by the embryonic yolk sac and the foetal liver. The enormous patient pool and heightening spending on healthcare are further fuelling the progress of the Alpha-Fetoprotein Testing Market in the Asia-Pacific region.
Surging Applications Of Alpha-Fetoprotein For Detection Of Neural Tube Defects And Chromosomal Abnormalities Are Projected To Drive The Growth Of Alpha-Fetoprotein Testing Market:
Since its launch into obstetric practice, maternal serum alpha-fetoprotein (MSAFP) screening has evolved into the first noninvasive biochemical test to offer information concerning the foetus. Its utility has extended from recognizing pregnancies at a soaring hazard of neural tube defects to discovering additional structural and chromosomal abnormalities of the foetus. MSAFP screening reduces morbidity and mortality by advancing access to earlier diagnosis, allowing families to make informed reproductive selections, and planning suitable strategies for prenatal care and delivery. Normal generation of alpha-fetoprotein (AFP) is rare to foetal development, making it a perfect marker for early foetal investigation. The surging applications of alpha-fetoprotein are therefore fuelling the growth of the Alpha-Fetoprotein Testing Market during the forecast period 2024-2030.
Proliferating Applications Of Alpha-Fetoprotein For Treatment Of Autoimmune Ailments And Cancer Are Expected To Boost The Demand Of Alpha-fetoprotein Testing Market:
Alpha-fetoprotein is a shuttle protein that transfers nutrients by way of receptor-mediated endocytosis to embryonic cells. In mature grown-ups, alpha-fetoprotein can shuttle medications into alpha-fetoprotein receptor-positive myeloid-derived suppressors, regenerating and also cancer cells. Medications with a high-binding affinity to alpha-fetoprotein can stimulate or drain targeted cells. Myeloid-derived suppressor cells stimulation results in immune suppression that can be utilized for treating autoimmune ailments. On the other hand, toxins transferred by alpha-fetoprotein can harm myeloid-derived suppressor cells and thereupon discharge innate and adaptive immunity to demolish cancer cells. Innate immunity natural killers decrease cancer stem cells and metastases. The novel alpha-fetoprotein medication noncovalent complexes for immunotherapy alter the local immune balance and hold potential in oncology, autoimmune and infectious ailments treatment, inflammation, transplantation, and vaccination. The proliferating applications of alpha-fetoprotein for the treatment of autoimmune ailments and cancer apart from detecting neural tube defects are driving the growth of the Alpha-fetoprotein (AFP) Testing Market during the forecast period 2022-2027.
Existence Of False Positive Results And False Negative Results Are Hampering The Growth Of The Alpha-Fetoprotein Testing Market:
A multiple marker test is not diagnostic. This means that it is not 100% precise. It is just a screening test to observe those who may require greater tests for their pregnancy. There may be false positive outcomes. These outcomes demonstrate an issue when the baby is in fact healthy. Similarly, there may be false-negative outcomes. False-negative outcomes demonstrate that all is normal when in fact the baby does have a health issue. These issues are thus hampering the growth of the Alpha-fetoprotein (AFP) Testing Market.
Alpha-Fetoprotein Testing Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and R&D Activities are key strategies adopted by players in the Alpha-fetoprotein (AFP) Testing Market. Key companies of this market are:
- Abbott Laboratories
- Labcorp
- Roche Diagnostics
- Thermo Fisher Scientific
- MP Biomedicals
- Bio-Rad Laboratories
- Beckman Coulter
- Siemens Healthcare
- Kreatech Diagnostics
- GeneCopoeia, Inc
Recent Developments
- In December 2021, Roche declared the introduction of NAVIFY® Oncology Hub, its most-recent digital solution to further improve clinical decision backing and workflow optimization for oncologists and oncology care teams. Oncologists frequently encounter incomplete patient records and data silos across multiple IT systems. This makes it hard to discover and accumulate all relevant data to acquire the complete picture of the patient’s health history and evaluate every case holistically.
- In November 2021, Roche declared the introduction of the cobas® 5800 System, a novel molecular laboratory tool, in countries receiving the CE mark. Testing is one of the earliest lines of defense to safeguard a patient’s general well-being and is vital in speedily guiding their treatment. The cobas 5800 System assists in attending to challenges that the laboratories are encountering from a boost in patient testing, reimbursement complications, and the requirement for a more diverse testing menu while offering significant and timely outcomes.
- In April 2020, Abbott introduced its third test for coronavirus (COVID-19) and is shipping tests to hospitals across the U.S. The test is a serology test – also termed an antibody test – which could be a crucial next step in combating this virus. Abbott's test assists to discover the IgG antibody to SARS-CoV-2.
Key Market Players:
The Top 5 companies in Alpha-Fetoprotein Testing Market are:
- Abbott Laboratories
- Labcorp
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific
- Portea Medical
For more Lifesciences and Healthcare related reports, please click here
List of Tables
Table1 Alpha-fetoprotein (AFP) Testing Market Overview 2023-2030
Table2 Alpha-fetoprotein (AFP) Testing Market Leader Analysis 2023-2030 (US$)
Table3 Alpha-fetoprotein (AFP) Testing MarketProduct Analysis 2023-2030 (US$)
Table4 Alpha-fetoprotein (AFP) Testing MarketEnd User Analysis 2023-2030 (US$)
Table5 Alpha-fetoprotein (AFP) Testing MarketPatent Analysis 2013-2023* (US$)
Table6 Alpha-fetoprotein (AFP) Testing MarketFinancial Analysis 2023-2030 (US$)
Table7 Alpha-fetoprotein (AFP) Testing Market Driver Analysis 2023-2030 (US$)
Table8 Alpha-fetoprotein (AFP) Testing MarketChallenges Analysis 2023-2030 (US$)
Table9 Alpha-fetoprotein (AFP) Testing MarketConstraint Analysis 2023-2030 (US$)
Table10 Alpha-fetoprotein (AFP) Testing Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table11 Alpha-fetoprotein (AFP) Testing Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table12 Alpha-fetoprotein (AFP) Testing Market Threat of Substitutes Analysis 2023-2030 (US$)
Table13 Alpha-fetoprotein (AFP) Testing Market Threat of New Entrants Analysis 2023-2030 (US$)
Table14 Alpha-fetoprotein (AFP) Testing Market Degree of Competition Analysis 2023-2030 (US$)
Table15 Alpha-fetoprotein (AFP) Testing MarketValue Chain Analysis 2023-2030 (US$)
Table16 Alpha-fetoprotein (AFP) Testing MarketPricing Analysis 2023-2030 (US$)
Table17 Alpha-fetoprotein (AFP) Testing MarketOpportunities Analysis 2023-2030 (US$)
Table18 Alpha-fetoprotein (AFP) Testing MarketProduct Life Cycle Analysis 2023-2030 (US$)
Table19 Alpha-fetoprotein (AFP) Testing MarketSupplier Analysis 2023-2030 (US$)
Table20 Alpha-fetoprotein (AFP) Testing MarketDistributor Analysis 2023-2030 (US$)
Table21 Alpha-fetoprotein (AFP) Testing Market Trend Analysis 2023-2030 (US$)
Table22 Alpha-fetoprotein (AFP) Testing Market Size 2023 (US$)
Table23 Alpha-fetoprotein (AFP) Testing Market Forecast Analysis 2023-2030 (US$)
Table24 Alpha-fetoprotein (AFP) Testing Market Sales Forecast Analysis 2023-2030 (Units)
Table25 Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2023-2030 ($)
Table26 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Liver Cancer, 2023-2030 ($)
Table27 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Testes Cancer, 2023-2030 ($)
Table28 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Ovarian Cancer, 2023-2030 ($)
Table29 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Biliary Tract Cancer, 2023-2030 ($)
Table30 Alpha-fetoprotein (AFP) Testing MarketBy Cancer Type, Revenue & Volume,By Stomach Cancer, 2023-2030 ($)
Table31 North America Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2023-2030 ($)
Table32 South america Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2023-2030 ($)
Table33 Europe Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2023-2030 ($)
Table34 APAC Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2023-2030 ($)
Table35 Middle East & Africa Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2023-2030 ($)
Table36 Russia Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2023-2030 ($)
Table37 Israel Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,By Cancer Type, 2023-2030 ($)
Table38 Top Companies 2023 (US$)Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,,
Table39 Product Launch 2023-2030Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,,
Table40 Mergers & Acquistions 2023-2030Alpha-fetoprotein (AFP) Testing Market, Revenue & Volume,,
List of Figures
Figure 1 Overview of Alpha-fetoprotein (AFP) Testing Market 2023-2030
Figure 2 Market Share Analysis for Alpha-fetoprotein (AFP) Testing Market 2023 (US$)
Figure 3 Product Comparison in Alpha-fetoprotein (AFP) Testing Market 2023-2030 (US$)
Figure 4 End User Profile for Alpha-fetoprotein (AFP) Testing Market 2023-2030 (US$)
Figure 5 Patent Application and Grant in Alpha-fetoprotein (AFP) Testing Market 2013-2023* (US$)
Figure 6 Top 5 Companies Financial Analysis in Alpha-fetoprotein (AFP) Testing Market 2023-2030 (US$)
Figure 7 Market Entry Strategy in Alpha-fetoprotein (AFP) Testing Market 2023-2030
Figure 8 Ecosystem Analysis in Alpha-fetoprotein (AFP) Testing Market2023
Figure 9 Average Selling Price in Alpha-fetoprotein (AFP) Testing Market 2023-2030
Figure 10 Top Opportunites in Alpha-fetoprotein (AFP) Testing Market 2023-2030
Figure 11 Market Life Cycle Analysis in Alpha-fetoprotein (AFP) Testing Market
Figure 12 GlobalBy Cancer TypeAlpha-fetoprotein (AFP) Testing Market Revenue, 2023-2030 ($)
Figure 13 Global Alpha-fetoprotein (AFP) Testing Market - By Geography
Figure 14 Global Alpha-fetoprotein (AFP) Testing Market Value & Volume, By Geography, 2023-2030 ($)
Figure 15 Global Alpha-fetoprotein (AFP) Testing Market CAGR, By Geography, 2023-2030 (%)
Figure 16 North America Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 17 US Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 18 US GDP and Population, 2023-2030 ($)
Figure 19 US GDP – Composition of 2023, By Sector of Origin
Figure 20 US Export and Import Value & Volume, 2023-2030 ($)
Figure 21 Canada Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 22 Canada GDP and Population, 2023-2030 ($)
Figure 23 Canada GDP – Composition of 2023, By Sector of Origin
Figure 24 Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 25 Mexico Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 26 Mexico GDP and Population, 2023-2030 ($)
Figure 27 Mexico GDP – Composition of 2023, By Sector of Origin
Figure 28 Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 29 South America Alpha-fetoprotein (AFP) Testing MarketSouth America 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 30 Brazil Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 31 Brazil GDP and Population, 2023-2030 ($)
Figure 32 Brazil GDP – Composition of 2023, By Sector of Origin
Figure 33 Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 34 Venezuela Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 35 Venezuela GDP and Population, 2023-2030 ($)
Figure 36 Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 37 Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 38 Argentina Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 39 Argentina GDP and Population, 2023-2030 ($)
Figure 40 Argentina GDP – Composition of 2023, By Sector of Origin
Figure 41 Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 42 Ecuador Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 43 Ecuador GDP and Population, 2023-2030 ($)
Figure 44 Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 45 Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 46 Peru Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 47 Peru GDP and Population, 2023-2030 ($)
Figure 48 Peru GDP – Composition of 2023, By Sector of Origin
Figure 49 Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 50 Colombia Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 51 Colombia GDP and Population, 2023-2030 ($)
Figure 52 Colombia GDP – Composition of 2023, By Sector of Origin
Figure 53 Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 54 Costa Rica Alpha-fetoprotein (AFP) Testing MarketCosta Rica 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 55 Costa Rica GDP and Population, 2023-2030 ($)
Figure 56 Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 57 Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 58 Europe Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 59 U.K Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 60 U.K GDP and Population, 2023-2030 ($)
Figure 61 U.K GDP – Composition of 2023, By Sector of Origin
Figure 62 U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 63 Germany Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 64 Germany GDP and Population, 2023-2030 ($)
Figure 65 Germany GDP – Composition of 2023, By Sector of Origin
Figure 66 Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 67 Italy Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 68 Italy GDP and Population, 2023-2030 ($)
Figure 69 Italy GDP – Composition of 2023, By Sector of Origin
Figure 70 Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 71 France Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 72 France GDP and Population, 2023-2030 ($)
Figure 73 France GDP – Composition of 2023, By Sector of Origin
Figure 74 France Export and Import Value & Volume, 2023-2030 ($)
Figure 75 Netherlands Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 76 Netherlands GDP and Population, 2023-2030 ($)
Figure 77 Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 78 Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 79 Belgium Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 80 Belgium GDP and Population, 2023-2030 ($)
Figure 81 Belgium GDP – Composition of 2023, By Sector of Origin
Figure 82 Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 83 Spain Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 84 Spain GDP and Population, 2023-2030 ($)
Figure 85 Spain GDP – Composition of 2023, By Sector of Origin
Figure 86 Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 87 Denmark Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 88 Denmark GDP and Population, 2023-2030 ($)
Figure 89 Denmark GDP – Composition of 2023, By Sector of Origin
Figure 90 Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 91 APAC Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 92 China Alpha-fetoprotein (AFP) Testing MarketValue & Volume, 2023-2030
Figure 93 China GDP and Population, 2023-2030 ($)
Figure 94 China GDP – Composition of 2023, By Sector of Origin
Figure 95 China Export and Import Value & Volume, 2023-2030 ($)Alpha-fetoprotein (AFP) Testing MarketChina Export and Import Value & Volume, 2023-2030 ($)
Figure 96 Australia Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 97 Australia GDP and Population, 2023-2030 ($)
Figure 98 Australia GDP – Composition of 2023, By Sector of Origin
Figure 99 Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 100 South Korea Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 101 South Korea GDP and Population, 2023-2030 ($)
Figure 102 South Korea GDP – Composition of 2023, By Sector of Origin
Figure 103 South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 104 India Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 105 India GDP and Population, 2023-2030 ($)
Figure 106 India GDP – Composition of 2023, By Sector of Origin
Figure 107 India Export and Import Value & Volume, 2023-2030 ($)
Figure 108 Taiwan Alpha-fetoprotein (AFP) Testing MarketTaiwan 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 109 Taiwan GDP and Population, 2023-2030 ($)
Figure 110 Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 111 Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 112 Malaysia Alpha-fetoprotein (AFP) Testing MarketMalaysia 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 113 Malaysia GDP and Population, 2023-2030 ($)
Figure 114 Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 115 Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 116 Hong Kong Alpha-fetoprotein (AFP) Testing MarketHong Kong 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 117 Hong Kong GDP and Population, 2023-2030 ($)
Figure 118 Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 119 Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 120 Middle East & Africa Alpha-fetoprotein (AFP) Testing MarketMiddle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 121 Russia Alpha-fetoprotein (AFP) Testing MarketRussia 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 122 Russia GDP and Population, 2023-2030 ($)
Figure 123 Russia GDP – Composition of 2023, By Sector of Origin
Figure 124 Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 125 Israel Alpha-fetoprotein (AFP) Testing Market Value & Volume, 2023-2030 ($)
Figure 126 Israel GDP and Population, 2023-2030 ($)
Figure 127 Israel GDP – Composition of 2023, By Sector of Origin
Figure 128 Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 129 Entropy Share, By Strategies, 2023-2030* (%)Alpha-fetoprotein (AFP) Testing Market
Figure 130 Developments, 2023-2030*Alpha-fetoprotein (AFP) Testing Market
Figure 131 Company 1 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 132 Company 1 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 133 Company 1 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 134 Company 2 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 135 Company 2 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 136 Company 2 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 137 Company 3Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 138 Company 3Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 139 Company 3Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 140 Company 4 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 141 Company 4 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 142 Company 4 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 143 Company 5 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 144 Company 5 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 145 Company 5 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 146 Company 6 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 147 Company 6 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 148 Company 6 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 149 Company 7 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 150 Company 7 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 151 Company 7 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 152 Company 8 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 153 Company 8 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 154 Company 8 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 155 Company 9 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 156 Company 9 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 157 Company 9 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 158 Company 10 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 159 Company 10 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 160 Company 10 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 161 Company 11 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 162 Company 11 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 163 Company 11 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 164 Company 12 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 165 Company 12 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 166 Company 12 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 167 Company 13Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 168 Company 13Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 169 Company 13Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 170 Company 14 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 171 Company 14 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 172 Company 14 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)
Figure 173 Company 15 Alpha-fetoprotein (AFP) Testing Market Net Revenue, By Years, 2023-2030* ($)
Figure 174 Company 15 Alpha-fetoprotein (AFP) Testing Market Net Revenue Share, By Business segments, 2023 (%)
Figure 175 Company 15 Alpha-fetoprotein (AFP) Testing Market Net Sales Share, By Geography, 2023 (%)